相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。ACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma
Prateek Khanna et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Expression of Components of the Renin-Angiotensin System by Cancer Stem Cells in Renal Clear Cell Carcinoma
Sam Siljee et al.
BIOMOLECULES (2021)
Development of a mechanically matched silk scaffolded 3D clear cell renal cell carcinoma model
Alycia Abbott et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathway
Yuan-yuan Jia et al.
JOURNAL OF CANCER (2021)
MatrisomeDB: the ECM-protein knowledge database
Xinhao Shao et al.
NUCLEIC ACIDS RESEARCH (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Exploring mechanisms of increased cardiovascular disease risk with antipsychotic medications: Risperidone alters the cardiac proteomic signature in mice
Megan Beauchemin et al.
PHARMACOLOGICAL RESEARCH (2020)
Inhibiting WNT and NOTCH in renal cancer stem cells and the implications for human patients
Annika Fendler et al.
NATURE COMMUNICATIONS (2020)
Organoid Models of Tumor Immunology
Kanako Yuki et al.
TRENDS IN IMMUNOLOGY (2020)
Targeting the HIF2-VEGF axis in renal cell carcinoma
Toni K. Choueiri et al.
NATURE MEDICINE (2020)
Establishment of patient-derived cancer organoids for drug-screening applications
Else Driehuis et al.
NATURE PROTOCOLS (2020)
Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy
Laura K. Esser et al.
FRONTIERS IN ONCOLOGY (2020)
Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice
Bahman Rostama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A framework for advancing our understanding of cancer-associated fibroblasts
Erik Sahai et al.
NATURE REVIEWS CANCER (2020)
Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
Yuxin Lin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Integrated cancer tissue engineering models for precision medicine
Michael E. Bregenzer et al.
PLOS ONE (2019)
Organoid technology in cancer precision medicine
Xinyi Xia et al.
CANCER LETTERS (2019)
Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells
Chenxi Tian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening
Minsuh Kim et al.
NATURE COMMUNICATIONS (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
Brian Rini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Notch2 and Proteomic Signatures in Mouse Neointimal Lesion Formation
Sarah M. Peterson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer
Ana Costa et al.
CANCER CELL (2018)
Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal
Thomas J. Mitchell et al.
CELL (2018)
SWATH mass spectrometry as a tool for quantitative profiling of the matrisome
Lukas Krasny et al.
JOURNAL OF PROTEOMICS (2018)
Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts
Diana Avery et al.
MATRIX BIOLOGY (2018)
Patient derived organoids to model rare prostate cancer phenotypes
Loredana Puca et al.
NATURE COMMUNICATIONS (2018)
Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo
Kevin D. Courtney et al.
CELL METABOLISM (2018)
Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells
Shi-Kun Guo et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors
Matthew D. Young et al.
SCIENCE (2018)
Organoid Modeling of the Tumor Immune Microenvironment
James T. Neal et al.
CELL (2018)
Tracing Renal Cell Carcinomas back to the Nephron
David Lindgren et al.
TRENDS IN CANCER (2018)
Renal Cancer Subtypes: Should We Be Lumping or Splitting for Therapeutic Decision Making?
Scott M. Haake et al.
CANCER (2017)
SWATH-ID: An instrument method which combines identification and quantification in a single analysis
Yang Kang et al.
PROTEOMICS (2017)
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Chantal Pauli et al.
CANCER DISCOVERY (2017)
Microenvironmental regulation of tumour angiogenesis
Michele de Palma et al.
NATURE REVIEWS CANCER (2017)
FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling
Xuguang Yang et al.
CANCER RESEARCH (2016)
The extracellular matrix: Tools and insights for the omics era
Alexandra Naba et al.
MATRIX BIOLOGY (2016)
SWATH Mass Spectrometry Performance Using Extended Peptide MS/MS Assay Libraries
Jemma X. Wu et al.
MOLECULAR & CELLULAR PROTEOMICS (2016)
LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival
Sofia Torres et al.
CLINICAL CANCER RESEARCH (2015)
Angiotensin System Inhibitors and Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma
Rana R. McKay et al.
CLINICAL CANCER RESEARCH (2015)
Three Dimensional Culture of Human Renal Cell Carcinoma Organoids
Cynthia A. Batchelder et al.
PLOS ONE (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Broad targeting of angiogenesis for cancer prevention and therapy
Zongwei Wang et al.
SEMINARS IN CANCER BIOLOGY (2015)
The evolving classification of renal cell neoplasia
Brett Delahunt et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2015)
Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients
Fangning Wan et al.
ONCOTARGET (2015)
IGFBP7, a novel tumor stroma marker, with growth-promoting effects in colon cancer through a paracrine tumor-stroma interaction
C. Rupp et al.
ONCOGENE (2015)
FOXD1 promotes nephron progenitor differentiation by repressing decorin in the embryonic kidney
Jennifer L. Fetting et al.
DEVELOPMENT (2014)
The VHL/HIF axis in clear cell renal carcinoma
Chuan Shen et al.
SEMINARS IN CANCER BIOLOGY (2013)
Collagen VI Ablation Retards Brain Tumor Progression Due to Deficits in Assembly of the Vascular Basal Lamina
Weon-Kyoo You et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK-p130Cas complex
Yu Wang et al.
JOURNAL OF CELL BIOLOGY (2012)
The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
Alexandra Naba et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis
Ludovic C. Gillet et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Soft fibrin gels promote selection and growth of tumorigenic cells
Jing Liu et al.
NATURE MATERIALS (2012)
Overview of the Matrisome-An Inventory of Extracellular Matrix Constituents and Functions
Richard O. Hynes et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
Peter Friedl et al.
CELL (2011)
Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium
Toshiro Sato et al.
GASTROENTEROLOGY (2011)
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
Mikala Egeblad et al.
DEVELOPMENTAL CELL (2010)
The polarization of immune cells in the tumour environment by TGFβ
Richard A. Flavell et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Kandice R. Levental et al.
CELL (2009)
Fibrin gels and their clinical and bioengineering applications
Paul A. Janmey et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2009)
Dimensionality reduction and visualization in principal component analysis
Gordana Ivosev et al.
ANALYTICAL CHEMISTRY (2008)
Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors
Michael L. Nickerson et al.
CLINICAL CANCER RESEARCH (2008)
Assembly and biological role of podosomes and invadopodia
Mario Gimona et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Stromal myofibroblasts are drivers of invasive cancer growth
Olivier De Wever et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions
E. R. Motrescu et al.
ONCOGENE (2008)
Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens
Jun Miki et al.
CANCER RESEARCH (2007)
Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment
Alexander R. A. Anderson et al.
CELL (2006)
β4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis
Wenjun Guo et al.
CELL (2006)
Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells:: pro-oncogenic effects mediated by PI3-kinase and NF-κB
S. W. Han et al.
ONCOGENE (2006)
Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways
SW Han et al.
CANCER RESEARCH (2006)
Tensional homeostasis and the malignant phenotype
MJ Paszek et al.
CANCER CELL (2005)
Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway
SD Bao et al.
CANCER CELL (2004)
TEM8 interacts with the cleaved C5 domain of collagen α3(VI)
A Nanda et al.
CANCER RESEARCH (2004)